Skip to main content
. 2020 Jan 31;11:17. doi: 10.3389/fimmu.2020.00017

Table 3.

Complement, leukocytes, and albumin in controls and necrotizing soft-tissue infection patients with and without septic shock.

Variable Total (N = 135) Controls (N = 65) Non-shock (N = 39) Septic shock (N = 96) p-value
MASP-1, AU/L 7.6 [6.5–8.9] 8.7 [7.5–10.2]a 8.4 [6.8–9.3] 7.4 [6.3–8.7]b 0.0017
MASP-2, AU/L 793.4 [504.1–1121.0] 977.5 [623.3–1464.3] 905.1 [551.9–1422.5] 717.3 [487.6–1015.0] 0.0390
MASP-3, AU/L 65.4 [47.5–100.5] 109.3 [87.9–130.1]ca 65.4 [48.4–86.2]b 65.5 [46.5–113.7]b <0.0001
C4, g/Ld 0.17 [0.14–0.24] 0.24 [0.20–0.31]ca 0.17 [0.14–0.26]b 0.17 [0.13–0.24]b <0.0001
C4c AU/L 134.6 [87.3–199.0] 194.7 [130.9–326.5]a 158.2 [106.1–261.4] 125.9 [80.7–188.8]b <0.0001
C4c/C4d 752.9 [507.1–1165.8] 855.3 [569.8–1391.0] 958.6 [522.1–1442.3] 671.5 [506.0–1086.0] 0.0828
C3, g/Ld 0.93 [0.75–1.2] 1.2 [1.1–1.4]ca 1.04 [0.82–1.4]ba 0.89 [0.73–1.08]bc <0.0001
C3bc, AU/L 15.7 [9.2–24.2]14.7 [9.1–22.0] 12.5 [9.1–18.4] 17.0 [9.5–22.4] 15.6 [9.1–24.2] 0.2460
C3bc/C3d 16.5 [10.3–27.0] 10.7 [7.7,14.7]ca 15.2 [9.3,23.0]b 16.7 [10.4,27.3]b 0.0002
TCC AU/L 1.5 [1.00–2.6] 0.35 [0.26–0.46]ca 1.3 [0.68–1.8]ba 1.7 [1.1–2.8]bc <0.0001
Leukocyte count, × 10/l, highest value 16.9 [10.4–23.9] 7.2 [6.3–9.3]ca 15.5 [9.7–22.7]b 17.6 [12.3–24.4]b <0.0001
C-reactive protein, mg/Ld 222.0 [141.0–298.0] 2.0 [1.00–4.0]ca 201.0 [134.0–275.0]b 222.0 [154.0–301.5]b <0.0001
Albumin, g/L 20.0 [16.0–22.0] 39.0 [36.0–41.0]ca 21.0 [18.0–23.0]b 18.5 [15.0–22.0]b <0.0001

Values presented as Median [IQR] with Kruskal-Wallis test. A significance level of 0.0167 was used for pairwise ad-hoc comparisons. Septic shock defined by criteria of Bone et al. (18).

a

Significantly different from Septic Shock.

b

Significantly different from controls.

c

Significantly different from non-shock.

d

Data not available for all subjects. Missing values: C4 (n = 4), C4c/C4 (n = 4) C3 (n = 4), C3bc/c3 (n = 4), leukocyte count (n = 3), and CRP (n = 4).